首页> 美国卫生研究院文献>Springer Open Choice >Identification of a novel flow-mediated gene expression signature in patients with bicuspid aortic valve
【2h】

Identification of a novel flow-mediated gene expression signature in patients with bicuspid aortic valve

机译:二尖瓣主动脉瓣患者中新的流介导的基因表达特征的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Individuals with bicuspid aortic valve (BAV) are at significantly higher risk of developing serious aortic complications than individuals with tricuspid aortic valves (TAV). Studies have indicated an altered aortic blood flow in patients with BAV; however, the extent to which altered flow influences the pathological state of BAV aorta is unclear. In the present study, we dissected flow-mediated aortic gene expression in patients undergoing elective open heart surgery. A large collection of public microarray data sets were firstly screened for consistent co-expression with five well-characterized flow-regulated genes (query genes). Genes with co-expression probability of >0.5 were selected and further analysed in expression profiles (127 arrays) from ascending aorta of BAV and TAV patients. Forty-four genes satisfied two filtering criteria: a significant correlation with one or more of the query genes (R > 0.40) and differential expression between patients with BAV and TAV. No gene fulfilled the criteria in mammary artery (88 arrays), an artery not in direct contact with the valve. Fifty-five percent of the genes significantly altered between BAV and TAV patients showed differential expression between two identified flow regions in the rat aorta. A large proportion of the identified genes were related to angiogenesis and/or wound healing, with pro-angiogenesis genes downregulated and inhibitory genes upregulated in patients with BAV. Moreover, differential expression of ZFP36, GRP116 and PKD2 was confirmed using immunohistochemistry. Implementing a new strategy, we have demonstrated an angiostatic gene expression signature in patients with BAV, indicating impaired wound healing in these patients, potentially involved in BAV-associated aortopathy.Electronic supplementary materialThe online version of this article (doi:10.1007/s00109-012-0942-8) contains supplementary material, which is available to authorized users.
机译:与三尖瓣主动脉瓣(TAV)个体相比,双尖瓣主动脉瓣(BAV)个体发生严重主动脉并发症的风险明显更高。研究表明,BAV患者的主动脉血流发生了改变。然而,改变的流量影响BAV主动脉病理状态的程度尚不清楚。在本研究中,我们解剖了接受择期开放性心脏手术的患者中血流介导的主动脉基因表达。首先对大量的公共微阵列数据集进行筛选,以与五个特征明确的流量调节基因(查询基因)保持一致的共表达。选择共表达概率> 0.5的基因,并在BAV和TAV患者升主动脉的表达谱(127个阵列)中进行进一步分析。 44个基因满足两个过滤标准:与一个或多个查询基因显着相关(R> 0.40)以及BAV和TAV患者之间的差异表达。乳动脉(不与瓣膜直接接触)(88个阵列)中没有基因符合标准。在BAV和TAV患者之间显着改变的基因的55%显示了大鼠主动脉中两个已确定的血流区域之间的差异表达。在BAV患者中,大部分已鉴定的基因与血管生成和/或伤口愈合有关,促血管生成基因被下调而抑制基因被上调。此外,使用免疫组织化学证实了ZFP36,GRP116和PKD2的差异表达。实施新策略后,我们已经证明了BAV患者的血管抑制基因表达特征,表明这些患者的伤口愈合受损,可能与BAV相关的主动脉病变有关。电子补充材料本文的在线版本(doi:10.1007 / s00109-012) -0942-8)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号